Filter Results :

Your search for Immune returned 106 reports

Sort by


AC Immune SA (ACIU) - Medical Equipment - Deals and Alliances Profile

06 Apr 2017  |  Published by:  GlobalData
SummaryAC Immune SA (AC Immune) is a clinical stage biopharmaceutical company that focuses on the design, discovery, and development of products for modifying and preventing diseases caused due to misfolded proteins. Its pipeline includes therapeutic and diagnostic candidates targeted at the treatme...

$ 250.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2017

22 Mar 2017  |  Published by:  Global Markets Direct
SummaryIdiopathic Thrombocytopenic Purpura - Pipeline Review, H1 2017, provides an overview of the Idiopathic Thrombocytopenic Purpura (Hematological Disorders) pipeline landscape.Idiopathic thrombocytopenic purpura is a bleeding disorder in which the immune system destroys platelets, which play imp...

$ 2,000.00

Read More

Altimmune Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

10 Mar 2017  |  Published by:  GlobalData
SummaryAltimmune Inc (Altimmune), formerly Vaxin Inc, is a clinical stage immunotherapeutic biotechnology company that develops vaccines and other biological products. The company's products include innovative vaccine delivery platforms, immunotherapeutic products, intranasally administered recombin...

$ 250.00

Read More

Altimmune UK Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

10 Mar 2017  |  Published by:  GlobalData
SummaryAltimmune UK Ltd (Altimmune), formerly Vaxin UK Limited, a subsidiary of Altimmune Inc, is a clinical stage immunotherapeutic biotechnology company that develops synthetic vaccines for mutating viruses. The company designs and develops immunotherapeutic products tailored to address a wide ran...

$ 250.00

Read More

Calimmune Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

10 Mar 2017  |  Published by:  GlobalData
SummaryCalimmune Inc (Calimmune) is a clinical-stage biotechnology company that focuses on the development of novel gene therapies that have the capability to enhance the immune systems of individuals. The company's lead candidate, CAL-1, is being developed to prevent the progression of HIV to AIDS ...

$ 250.00

Read More

Primary Immune Deficiency (PID) - Pipeline Review, H1 2017

08 Mar 2017  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) – Pipeline Review, H1 2017, provides an overview of the Primary Immune Deficiency (PID) (Genetic Disorders) pipeline landscape.Primary immunodeficiency is defined as weaken immu...

$ 2,000.00

Read More

Immune Checkpoints Activators - Competitive Landscape, Technology and Pipeline Analysis, 2017

02 Mar 2017  |  Published by:  DelveInsight
Immune Checkpoints Activators- Competitive Landscape, Technology and Pipeline Analysis, 2017”, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for all the marketed and  pipeli...

$ 2,250.00

Read More

Global Immune Check Point Inhibitors Market & Clinical Pipeline Insight 2022

01 Mar 2017  |  Published by:  KuicK Research
“Global Immune Check Point Inhibitors Market & Clinical Pipeline Insight 2022” report gives comprehensive insight on clinical and non-clinical aspects involved in the development and integration of immune check point inhibitors as main streamline drugs in the immunotherapy treatment. Report help...

$ 2,400.00

Read More

Global Autoimmune Partnering 2010-2017: Deal trends, players and financials

01 Mar 2017  |  Published by:  CurrentPartnering
Global Autoimmune Partnering 2010 to 2017 provides the full collection of Autoimmune disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.-Trends in Autoimmune partnering deals-Financial deal terms for headline, upfront and royalty by stage of development-Au...

$ 2,995.00

Read More

Acquired (Autoimmune) Hemolytic Anemia Global Clinical Trials Review, H1, 2017

22 Feb 2017  |  Published by:  GlobalData
Summary“Acquired (Autoimmune) Hemolytic Anemia Global Clinical Trials Review, H1, 2017" provides an overview of Acquired (Autoimmune) Hemolytic Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Acquired (Autoimmune) Hemolytic Anemia. Report includ...

$ 2,500.00

Read More

MedImmune Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

17 Feb 2017  |  Published by:  GlobalData
SummaryMedImmune Ltd (MedImmune), a subsidiary of AstraZeneca Plc is a biotechnology company that develops and commercializes small molecule and biologic prescription medicines for the prevention of respiratory tract disease caused by respiratory syncytial virus. The company's products include synag...

$ 250.00

Read More

Global Autoimmune Disease Therapeutics Market Research Report 2017

14 Feb 2017  |  Published by:  QYResearch
Notes:Production, means the output of Autoimmune Disease TherapeuticsRevenue, means the sales value of Autoimmune Disease TherapeuticsThis report studies Autoimmune Disease Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manu...

$ 2,900.00

Read More

Global Autoimmune Treatment Market Research Report 2017

14 Feb 2017  |  Published by:  QYResearch
Notes:Production, means the output of Autoimmune TreatmentRevenue, means the sales value of Autoimmune TreatmentThis report studies Autoimmune Treatment in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with ...

$ 2,900.00

Read More

Global Immune Checkpoint Inhibitors Market Research Report 2017

06 Feb 2017  |  Published by:  9Dimen Research
Immune Checkpoint Inhibitors Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United S...

$ 2,850.00

Read More

AC Immune SA (ACIU) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

25 Jan 2017  |  Published by:  GlobalData
SummaryAC Immune SA (AC Immune) is a clinical stage biopharmaceutical company that focuses on the design, discovery, and development of products for modifying and preventing diseases caused due to misfolded proteins. Its pipeline includes therapeutic and diagnostic candidates targeted at the treatme...

$ 250.00

Read More
Total 106 records.